ZALTAG
Active Principle: Dasatinib.
Therapeutic Effect: Multiple tyrosine kinases inhibitor.
Composition: Each 50mg tablet contains: Dasatinib 50mg. Excipients q.s. Each 100mg tablet contains: Dasatinib 100mg. Excipients q.s.
How Supplied: ZALTAG 50mg: Blister packs with 30 and 60 coated tablets. ZALTAG 70mg: Blister packs with 30 coated tablets. ZALTAG 100mg:
Blister packs with 30 coated tablets.
